A session led by Dr. Mehdi Rashighi, a physician-scientist and an assistant professor of dermatology at the University of Massachusetts Medical School in Worcester, focused on new therapies for inflammatory skin diseases. Historically, treatments for these conditions were often off-label, but advances in understanding their pathogenesis have led to the development of targeted therapies like JAK inhibitors and monoclonal antibodies.
Uncover the advancements in dermatology as they provide new hope for patients with various inflammatory skin diseases.